SCHEMBL31708191

SCHEMBL31708191

CNC(=O)C(=O)c1c[nH]c2cc(F)cc(O)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.44
▸ GABRP O00591 4/20 0.35
▸ GABRD O14764 4/20 0.35
▸ GABRA1 P14867 4/20 0.35
▸ GABRB1 P18505 4/20 0.35
▸ GABRG2 P18507 4/20 0.35
▸ GABRB3 P28472 4/20 0.35
▸ GABRA5 P31644 4/20 0.35
▸ GABRA3 P34903 4/20 0.35
▸ GABRA2 P47869 4/20 0.35
▸ GABRB2 P47870 4/20 0.35
▸ GABRA4 P48169 4/20 0.35
▸ GABRE P78334 4/20 0.35
▸ GABRA6 Q16445 4/20 0.35
▸ GABRG1 Q8N1C3 4/20 0.35
▸ GABRG3 Q99928 4/20 0.35
▸ GABRQ Q9UN88 4/20 0.35
▸ IGF1R P08069 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ MPO P05164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31708151 0.74 IGF1R (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30712084 0.74 IGF1R (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL13325448 0.70 CES2 (0.38) HTR1A
SCHEMBL31708141 0.68 NR4A2 (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31708047 0.67 GABRP (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL25423716 0.67 CES2 (0.38) HTR1A
SCHEMBL31708139 0.67 HTR1A (0.66) HTR1AMPO
SCHEMBL25748764 0.67 HTR1A (0.39) HTR1A
SCHEMBL17303510 0.66 GAA (0.36) —
SCHEMBL29953426 0.66 HTR1A (0.47) HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback